BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 33991162)

  • 1. 20 Post-COVID-19 vaccine-related shingles cases seen at the Las Vegas Dermatology clinic and sent to us via social media.
    Lee C; Cotter D; Basa J; Greenberg HL
    J Cosmet Dermatol; 2021 Jul; 20(7):1960-1964. PubMed ID: 33991162
    [No Abstract]   [Full Text] [Related]  

  • 2. Herpes zoster following inactivated COVID-19 vaccine: A coexistence or coincidence?
    Bostan E; Yalici-Armagan B
    J Cosmet Dermatol; 2021 Jun; 20(6):1566-1567. PubMed ID: 33638924
    [No Abstract]   [Full Text] [Related]  

  • 3. Herpes zoster following COVID-19 vaccine: a report of three cases.
    Chiu HH; Wei KC; Chen A; Wang WH
    QJM; 2021 Nov; 114(7):531-532. PubMed ID: 34293165
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpes zoster after COVID-19 vaccination-Can the vaccine reactivate latent zoster virus?
    Palanivel JA
    J Cosmet Dermatol; 2021 Nov; 20(11):3376-3377. PubMed ID: 34559453
    [No Abstract]   [Full Text] [Related]  

  • 5. Herpes Zoster following SARS-CoV-2 vaccination - a series of four cases.
    Alpalhão M; Filipe P
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e750-e752. PubMed ID: 34310754
    [No Abstract]   [Full Text] [Related]  

  • 6. Herpes zoster after inactivated COVID-19 vaccine: A cutaneous adverse effect of the vaccine.
    Arora P; Sardana K; Mathachan SR; Malhotra P
    J Cosmet Dermatol; 2021 Nov; 20(11):3389-3390. PubMed ID: 34077622
    [No Abstract]   [Full Text] [Related]  

  • 7. Plantar herpes zoster following heterologous recombinant adenovirus-based COVID-19 vaccine.
    Ayatollahi A; Robati RM; Firooz A
    J Cosmet Dermatol; 2022 Jan; 21(1):34-35. PubMed ID: 34757689
    [No Abstract]   [Full Text] [Related]  

  • 8. Analyzing the attitude of Indian citizens towards COVID-19 vaccine - A text analytics study.
    Praveen SV; Ittamalla R; Deepak G
    Diabetes Metab Syndr; 2021; 15(2):595-599. PubMed ID: 33714134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on "An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology".
    Speeckaert R; Lambert J; Puig L; Speeckaert M; Lapeere H; De Schepper S; van Geel N
    J Am Acad Dermatol; 2021 Aug; 85(2):e89-e90. PubMed ID: 33744352
    [No Abstract]   [Full Text] [Related]  

  • 10. Disseminated herpes zoster following inactivated SARS-CoV-2 vaccine in a healthy old man.
    Zhang LW; Fu LX; Meng HM; Lu YH; Chen T
    Eur J Dermatol; 2022 May; 32(3):415-416. PubMed ID: 36065551
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to comment on "An evidence-based guide to SARS-Cov-2 vaccination of patients on immunotherapies in dermatology.".
    Gresham LM; Marzario B; Dutz J; Kirchhof MG
    J Am Acad Dermatol; 2021 Aug; 85(2):e91. PubMed ID: 33878412
    [No Abstract]   [Full Text] [Related]  

  • 12. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoting COVID-19 Vaccination on Social Media.
    Raza F; Lantos JD
    Pediatrics; 2021 May; 147(5):. PubMed ID: 33853889
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic.
    Maia CMF; Marques NP; de Lucena EHG; de Rezende LF; Martelli DRB; Martelli-Júnior H
    Int J Infect Dis; 2021 Mar; 104():732-733. PubMed ID: 33582367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tribal Sovereignty in Research and Community Engagement for a COVID-19 Vaccine Clinical Trial on the Navajo Nation: Beyond a Facebook Town Hall.
    Hammitt LL; Vigil DE; Reid R
    Am J Public Health; 2021 Aug; 111(8):1431-1432. PubMed ID: 34464194
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford-AstraZeneca COVID-19 vaccine: report of three cases from India.
    Mehta H; Handa S; Malhotra P; Patial M; Gupta S; Mukherjee A; Chatterjee D; Takkar A; Mahajan R
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e16-e18. PubMed ID: 34547126
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrent herpes zoster after COVID-19 vaccination in patients with chronic urticaria being treated with cyclosporine-A report of 3 cases.
    Mohta A; Arora A; Srinivasa R; Mehta RD
    J Cosmet Dermatol; 2021 Nov; 20(11):3384-3386. PubMed ID: 34510694
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer.
    Maranini B; Ciancio G; Cultrera R; Govoni M
    Reumatismo; 2022 May; 74(1):. PubMed ID: 35506316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to a letter to the editor regarding "Utilization of Instagram by Dermatology Residency Programs in the era of COVID-19".
    Schwartzman G; Qureshi A; Friedman AJ
    J Am Acad Dermatol; 2021 Nov; 85(5):e317. PubMed ID: 34403705
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral drugs and vaccines for herpes simplex and herpes zoster. Proceedings of a symposium. American Academy of Dermatology forty-fourth annual meeting. December 11, 1985, Las Vegas, NV.
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):161-238. PubMed ID: 3339137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 53.